These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 1912391)

  • 1. Plasma oxalate levels rise in hemodialysis patients despite increased oxalate removal.
    Costello JF; Sadovnic MJ; Cottington EM
    J Am Soc Nephrol; 1991 Jun; 1(12):1289-98. PubMed ID: 1912391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of vitamin B6 supplementation on plasma oxalate and oxalate removal rate in hemodialysis patients.
    Costello JF; Sadovnic MC; Smith M; Stolarski C
    J Am Soc Nephrol; 1992 Oct; 3(4):1018-24. PubMed ID: 1450364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of pyridoxine supplementation on plasma oxalate concentrations in patients receiving dialysis.
    Tomson CR; Channon SM; Parkinson IS; Sheldon WS; Ward MK; Laker MK
    Eur J Clin Invest; 1989 Apr; 19(2):201-5. PubMed ID: 2499479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma concentration and peritoneal clearance of oxalate in patients on continuous ambulatory peritoneal dialysis (CAPD).
    Yamauchi A; Fujii M; Shirai D; Mikami H; Okada A; Imai E; Ando A; Orita Y; Kamada T
    Clin Nephrol; 1986 Apr; 25(4):181-5. PubMed ID: 3698351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperoxalemia in renal failure and the role of hemoperfusion and hemodialysis in primary oxalosis.
    Ahmad S; Hatch M
    Nephron; 1985; 41(3):235-40. PubMed ID: 4058624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of ascorbic acid and pyridoxine supplementation on oxalate metabolism in peritoneal dialysis patients.
    Shah GM; Ross EA; Sabo A; Pichon M; Reynolds RD; Bhagavan H
    Am J Kidney Dis; 1992 Jul; 20(1):42-9. PubMed ID: 1621677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxalate dynamics and removal rates during haemodialysis and peritoneal dialysis in patients with primary hyperoxaluria and severe renal failure.
    Watts RW; Veall N; Purkiss P
    Clin Sci (Lond); 1984 May; 66(5):591-7. PubMed ID: 6368103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secondary hyperoxalemia caused by vitamin C supplementation in regular hemodialysis patients.
    Ono K
    Clin Nephrol; 1986 Nov; 26(5):239-43. PubMed ID: 3802587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma oxalate in patients with chronic renal failure receiving continuous ambulatory peritoneal dialysis or hemodialysis.
    McConnell KN; Rolton HA; Modi KS; Macdougall AI
    Am J Kidney Dis; 1991 Oct; 18(4):441-5. PubMed ID: 1928062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxalate removal by hemodialysis in end-stage renal disease.
    Ramsay AG; Reed RG
    Am J Kidney Dis; 1984 Sep; 4(2):123-7. PubMed ID: 6475942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal replacement therapy and secondary hyperoxalemia in chronic renal failure.
    Mydlík M; Derzsiová K
    Kidney Int Suppl; 2001 Feb; 78():S304-7. PubMed ID: 11169031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin C intoxication and hyperoxalemia in chronic hemodialysis patients.
    Pru C; Eaton J; Kjellstrand C
    Nephron; 1985; 39(2):112-6. PubMed ID: 3974772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperoxaluria and hyperoxalemia: one more concern for the nephrologist.
    Mitwalli A; Oreopoulos DG
    Int J Artif Organs; 1985 Mar; 8(2):71-4. PubMed ID: 3886558
    [No Abstract]   [Full Text] [Related]  

  • 14. Oxalate elimination via hemodialysis or peritoneal dialysis in children with chronic renal failure.
    Hoppe B; Graf D; Offner G; Latta K; Byrd DJ; Michalk D; Brodehl J
    Pediatr Nephrol; 1996 Aug; 10(4):488-92. PubMed ID: 8865249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term, low-dose, intravenous vitamin C leads to plasma calcium oxalate supersaturation in hemodialysis patients.
    Canavese C; Petrarulo M; Massarenti P; Berutti S; Fenoglio R; Pauletto D; Lanfranco G; Bergamo D; Sandri L; Marangella M
    Am J Kidney Dis; 2005 Mar; 45(3):540-9. PubMed ID: 15754276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determinants of oxalate balance in patients on chronic peritoneal dialysis.
    Marangella M; Bagnis C; Bruno M; Petrarulo M; Gabella P; Linari F
    Am J Kidney Dis; 1993 Apr; 21(4):419-26. PubMed ID: 8465823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contribution of dialysis to endogenous oxalate production in patients with chronic renal failure.
    France NC; Holland PT; Wallace MR
    Clin Chem; 1994 Aug; 40(8):1544-8. PubMed ID: 8044994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peritoneal clearance and peritoneal transfer of oxalic acid, vitamin C, and vitamin B6 during continuous ambulatory peritoneal dialysis.
    Mydlík M; Derzsiová K; Svác J; Dlhopolcek P; Zemberová E
    Artif Organs; 1998 Sep; 22(9):784-8. PubMed ID: 9754466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Oxalic acid metabolism in chronic renal failure].
    Balcke P
    Wien Klin Wochenschr Suppl; 1985; 160():1-15. PubMed ID: 3859955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Kinetics of oxalate in hemodialysis].
    Marangella M; Petrarulo M; Vitale C; Cosseddu D; Linari F
    Minerva Urol Nefrol; 1991; 43(3):165-9. PubMed ID: 1817340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.